🔗 Visit the ClinicalTrials.gov page for NCT00269412
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Safety and tolerability of rifaximin for the treatment of irritable bowel syndrome without constipation: a pooled analysis of randomised, double-blind, placebo-controlled trials. | Aliment Pharmacol Ther | 2014 | 2.17 |